Anthony Y. Sun - 04 Oct 2021 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
President & CEO, Director
Signature
By: /s/ Melissa B. Epperly, Attorney-in-Fact for Anthony Y. Sun
Issuer symbol
ZNTL
Transactions as of
04 Oct 2021
Net transactions value
-$1,777,707
Form type
4
Filing time
04 Oct 2021, 21:15:48 UTC
Previous filing
02 Sep 2021
Next filing
02 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Sale $690,136 -10,464 -0.81% $65.95 1,286,878 04 Oct 2021 Direct F1, F2
transaction ZNTL Common Stock Sale $1,085,757 -16,308 -1.3% $66.58 1,270,570 04 Oct 2021 Direct F1, F3
transaction ZNTL Common Stock Sale $1,813 -27 -0% $67.15 1,270,543 04 Oct 2021 Direct F1
holding ZNTL Common Stock 974,302 04 Oct 2021 By Essex Group International, LLC
holding ZNTL Common Stock 213,600 04 Oct 2021 See Footnote F4
holding ZNTL Common Stock 228,650 04 Oct 2021 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $65.15 to $66.14. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $66.15 to $67.09. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Represents shares nominally held by Hao Bao Zi Trust LLC on behalf of the Hao Bao Zi Trust (the "Trust"), the sole member of Hao Bao Zi Trust LLC. The Reporting Person's spouse is the investment adviser with sole power to make investment decisions regarding the securities held by the Trust. The Reporting Person disclaims beneficial ownership of the securities held by Hao Bao Zi Trust LLC except to the extent of his pecuniary interest therein, if any.